Lista de obras -

2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.

artículo científico publicado en 2005

Allosteric inhibitors of chemoattractant receptors: opportunities and pitfalls

artículo científico publicado en 2008

Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs).

artículo científico publicado en 2003

Chemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary cultures

scientific journal article

Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice

artículo científico publicado en 2007

Design of Noncompetitive Interleukin-8 Inhibitors Acting on CXCR1 and CXCR2

artículo científico publicado en 2007

Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.

artículo científico publicado en 2006

ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets

artículo científico publicado en 2006

Granulocyte colony-stimulating factor decreases tumor necrosis factor production in whole blood: role of interleukin-10 and prostaglandin E(2).

artículo científico publicado en 2004

Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2

artículo científico publicado en 2005

Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion

artículo científico publicado en 2005

Key role of proline-rich tyrosine kinase 2 in interleukin-8 (CXCL8/IL-8)-mediated human neutrophil chemotaxis.

artículo científico publicado en 2004

Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia.

artículo científico publicado en 2005

Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.

scholarly article

Reparixin, an Inhibitor of CXCR2 Function, Attenuates Inflammatory Responses and Promotes Recovery of Function after Traumatic Lesion to the Spinal Cord

article

Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

artículo científico publicado en 2004

Requirements for the different cysteines in the chemotactic and desensitizing activity of human thioredoxin

artículo científico publicado en 2005

Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis

artículo científico publicado en 2008

Structure-Activity Relationship of novel phenylacetic CXCR1 inhibitors

artículo científico publicado en 2009

Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief

artículo científico publicado en 2014

The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature

artículo científico publicado en 2008

The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats

artículo científico publicado en 2007

Thioredoxin specifically cross-desensitizes monocytes to MCP-1.

artículo científico publicado en 2002

Lista de obras de

2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.

Allosteric inhibitors of chemoattractant receptors: opportunities and pitfalls

Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs).

Chemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary cultures

Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice

Design of Noncompetitive Interleukin-8 Inhibitors Acting on CXCR1 and CXCR2

Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.

ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets

Granulocyte colony-stimulating factor decreases tumor necrosis factor production in whole blood: role of interleukin-10 and prostaglandin E(2).

Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2

Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion

Key role of proline-rich tyrosine kinase 2 in interleukin-8 (CXCL8/IL-8)-mediated human neutrophil chemotaxis.

Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia.

Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.

Reparixin, an Inhibitor of CXCR2 Function, Attenuates Inflammatory Responses and Promotes Recovery of Function after Traumatic Lesion to the Spinal Cord

Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

Requirements for the different cysteines in the chemotactic and desensitizing activity of human thioredoxin

Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis

Structure-Activity Relationship of novel phenylacetic CXCR1 inhibitors

Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief

The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature

The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats

Thioredoxin specifically cross-desensitizes monocytes to MCP-1.